![](/img/cover-not-exists.png)
2092 POSTER Comparison of cost-effectiveness of aromatase inhibitors letrozole, anastrozole or exemestane versus tamoxifen for early breast cancer in hormone receptor-positive postmenopausal women: Canadian perspective
K. El Ouagari, J. Karnon, S. KauraVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70854-6
File:
PDF, 77 KB
english, 2007